These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. New class of anti-HIV drugs. Stephenson J JAMA; 1999 Dec; 282(21):1994. PubMed ID: 10591371 [No Abstract] [Full Text] [Related]
5. A T-20 diary. Gormley F GMHC Treat Issues; 2002 Mar; 16(3):6-7. PubMed ID: 12004799 [No Abstract] [Full Text] [Related]
6. [HIV-1 fusion inhibitor improves treatment in HIV-1-resistant patients]. Blasko M Dtsch Med Wochenschr; 2003 May; 128(19):1032. PubMed ID: 12774800 [No Abstract] [Full Text] [Related]
7. Enfuvirtide (T-20): a novel human immunodeficiency virus type 1 fusion inhibitor. Cervia JS; Smith MA Clin Infect Dis; 2003 Oct; 37(8):1102-6. PubMed ID: 14523775 [TBL] [Abstract][Full Text] [Related]
8. T-20 small program, CD4 < 50, will enroll November 27 at 3:00 P.M. James JS AIDS Treat News; 2001 Oct; (373):3. PubMed ID: 11768880 [No Abstract] [Full Text] [Related]
9. New class of medications approved for advance HIV. FDA Consum; 2003; 37(3):5. PubMed ID: 12793380 [No Abstract] [Full Text] [Related]
10. [Initial retroviral drug with new mechanism of action. Peptide T-20 enriches therapeutic arsenal]. MMW Fortschr Med; 2003 Apr; 145 Spec No 1():55-7. PubMed ID: 15011591 [No Abstract] [Full Text] [Related]
11. HIV fusion and its inhibition. LaBranche CC; Galasso G; Moore JP; Bolognesi DP; Hirsch MS; Hammer SM Antiviral Res; 2001 May; 50(2):95-115. PubMed ID: 11369431 [No Abstract] [Full Text] [Related]
12. [Fusion inhibitors. One year therapy with T-20--initial evaluation]. Goebel FD MMW Fortschr Med; 2004 Apr; 146 Spec No 1():42-3. PubMed ID: 15373046 [No Abstract] [Full Text] [Related]
13. Fresh data on new anti-HIV drugs presented in Durban. Leibovich M Posit Living; 2000 Aug; 9(7):16-7. PubMed ID: 12492026 [No Abstract] [Full Text] [Related]